Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Jun 21.
Published in final edited form as: Chem Commun (Camb). 2010 Nov 2;46(47):8935–8937. doi: 10.1039/c0cc02945a

Photochemical cleavage of leader peptides,

Noah Bindman 1, Remco Merkx 1, Robert Koehler 1, Nicholas Herrman 1, Wilfred A van der Donk 1,*
PMCID: PMC3100556  NIHMSID: NIHMS293413  PMID: 21046030

Abstract

We report a photolabile linker compatible with Fmoc solid phase peptide synthesis and Cu(I)-catalyzed alkyne–azide cycloaddition that allows photochemical cleavage to afford a C-terminal peptide fragment with a native amino terminus.


The recent explosion of fully sequenced genomes has resulted in the discovery of over a dozen different classes of peptide-derived natural products that are DNA encoded.1 After peptide synthesis on the ribosome, extensive posttranslational modifications morph these peptides into their active form. In almost all known examples, an N-terminal leader peptide guides at least part of these posttranslational modifications, but the leader peptide must be removed from the core peptide in the final step of maturation to produce the active natural product (e.g.,Scheme 1).1In vitro reconstitution of the activities of a growing number of the biosynthetic enzymes of these natural products2 has started to be exploited for the generation of analogs by incorporation of non-proteinogenic amino acids into the peptide substrates for posttranslational modifications.3 However, the final removal of the leader peptide usually poses a major hurdle because the proteases that perform these steps are often membrane associated as part of ATP-binding cassette transporters4 or sometimes have not been identified at all. An alternative, general method for the removal of the leader peptides would therefore be valuable.

Scheme 1.

Scheme 1

Biosynthesis of lacticin 481. The synthetase LctM transforms a linear precursor peptide LctA into a polycyclic structure. The transporter LctT then removes the leader peptide and secretes the product lacticin 481.

The incorporation of 2-nitrophenyl or 2-nitroveratrole groups at appropriate sites in peptides and proteins has allowed the site-specific light-mediated cleavage of the polyamide backbone. For instance, introduction of phenylglycine derivative 1 in ion channels allowed their temporal photo-activation.5 Other examples of linkers that allow photo-lytic scission of peptide chains are the commercially available β-amino acid 26 and a series of linkers incorporating an aryl group in the peptide chain, exemplified by 3.6 These linkers are very effective but are less attractive for leader peptide removal as they would result in core peptides carrying nitrosoaryl groups (e.g. 9–11, Scheme 2). We therefore designed linker 4, which was envisioned to generate the native core peptide 12 upon photolysis.

Scheme 2.

Scheme 2

Photochemical cleavage of 2-nitrophenyl derivatives (14) into N- and C-terminal fragments. For the purpose of this work, R1 would represent the leader peptide and R2 the core peptide.

The synthetic route towards a reagent that could introduce linker 4 into peptides is depicted in Scheme 3A. Important design criteria were compatibility with Fmoc solid phase peptide synthesis (SPPS) and with our previously developed ligation strategy that links the leader peptide with the core peptide using a copper-catalyzed [2+3] cycloaddition7 between a leader peptide with a C-terminal alkyne and a core peptide with an N-terminal azide.3 Compound 17 fulfills both criteria as demonstrated herein. A related photolabile linker incorporating an azide was very recently reported that requires a more lengthy synthesis and that was not used for SPPS.8

Scheme 3.

Scheme 3

(A) Synthesis of photolabile linker 17. TsCl, 4-toluenesulfonyl chloride; TMSCl, trimethylsilyl chloride. (B) Synthesis of decapeptides 21ai followed by photolysis to produce peptides 22ai and 23ai. DIPEA, diisopropylethylamine; HOBt, hydroxybenzotriazole; DIC, diisopropylcarbodiimide.

Linker 17 was efficiently synthesized starting from commercial diol 13. Activationwith p-toluenesulfonyl chloride was followed by protection with trimethylsilyl (TMS) chloride to give 15. The p-toluenesulfonate group of 15 was then displaced with sodium azide. TMS protection was required to prevent epoxide formation and subsequent azide addition to the benzylic carbon. Fortuitously, under the displacement reaction conditions the TMS protecting group was slowly removed affording secondary alcohol 16. This compound was then reacted with disuccinimidyl carbonate to form activated linker 17. Compounds 16 and 17 were analyzed by differential scanning calorimetry to ensure their safety under the conditions used (see ESI).

To investigate the compatibility of linker 17 with Fmoc SPPS, a model peptide with the sequence TALSG (18a, Scheme 3B, Xxx1 = Thr) was assembled on pre-loaded Gly-Wang resin using standard Fmoc methodology with O-(1H-6-chlorobenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluoro-phosphate (HCTU) and N-methylmorpholine (NMM) as coupling agents. The peptide was reacted with linker 17 and the azide functionality was reduced in situ with tri-n-butyl-phosphine, followed by coupling with Fmoc-Ala-OH to give peptide 20a (Xxx2 = Ala). Standard peptide elongation steps were followed by peptide cleavage from the resin using 95% trifluoroacetic acid and HPLC purification producing 21a. The purified peptide was then irradiated at 365 nm and the photolysis reaction was complete within 1.5 h as judged by HPLC and MS (Fig. 1; Fig. S1, ESI).

Fig. 1.

Fig. 1

HPLC of peptide 21a before (red) and after (blue) photolysis. Linker 17 contains a stereogenic center and was prepared in racemic form, resulting in two diastereomers of peptide 21a. The two product peaks labeled with an asterisk are breakdown products of 22a.

In this and other studies9 it was observed that photo-lysis was accompanied by the formation of various strongly absorbing decomposition products arising from the nitrosoaryl group (Fig. 1). In the current design, however, these side products are not part of the desired C-terminal peptide fragment 23 as was confirmed by mass spectrometry.

The linker was incorporated next into a series of model peptides in which the amino acids preceding and following the linker were varied (Table 1). Upon photolysis, the desired C-terminal peptide was obtained successfully and in good yields and purities after HPLC in all cases (Table 1; Fig. S2–S17, ESI).

Table 1.

Synthesis and photolysis of peptides 21a-i using a variety of amino acids flanking the photolabile linker

graphic file with name nihms-293413-t0001.jpg

Yield (%)
Xxx1 Xxx2 21a 23b Per stepc
a Thr Ala 43 70 94
b Val Ala 21 72 90
c Lys Ala 27 87 93
d Gly Gly 39 83 94
e Leu Leu 44 61 93
f Tyr Tyr 16 83 90
g Pro Pro 17 81 90
h Trp Trp 14 70 83
i Glu Glu 21 91 92
a

Isolated yields based on resin loading.

b

Isolated yields after photolysis and HPLC based on 21.

c

Yields based on resin loading.

We next sought to apply the methodology to the preparation of the posttranslationally modified peptide natural product lacticin 481. The biogenesis of lacticin 481 commences with the ribosomal synthesis of the precursor peptide LctA. Sub-sequently, the bifunctional enzyme LctM dehydrates a series of Ser and Thr residues located in the core peptide of LctA to generate dehydroalanine (Dha) and dehydrobutyrine (Dhb) residues, respectively (Scheme 1).10 LctM also catalyzes the regio- and stereoselective intramolecular Michael-type addition of Cys residues to the dehydro amino acids, resulting in lanthionine and methyllanthionine crosslinks. In the last step of the biosynthesis the protease domain of the transmembrane transporter LctT proteolytically removes the leader peptide.11 Whereas LctM activity has been reconstituted in vitro, previous studies utilized the commercial protease Lys-C to remove the leader peptide, which produces Δ1-lacticin 481 lacking the N-terminal Lys.10,12

To evaluate whether light-mediated leader peptide removal could yield full length lacticin 481, the core peptide of lacticin 481 was synthesized on pre-loaded Wang resin by SPPS and linker 17 was added (Scheme 4A). After cleavage from the resin and HPLC purification, peptide 25 was used for copper catalyzed [2+3] cycloaddition with the leader peptide carrying a C-terminal alkyne group (26). The resulting substrate analog was incubated with LctM resulting in the anticipated four dehydrations (Scheme 4B). Subsequent photolysis afforded mature lacticin 481 (see ESI). Thus, this methodology can be utilized for the preparation of native lacticin 481 and can be extended to the preparation of analogs using previously published procedures.3 This methodology adds one linear step (the addition of linker 17) compared to our previous approach using a protease to remove the leader. However, unlike the protease approach with LysC, light- mediated removal of the leader peptide is not sequence dependent and provides the full length natural product, providing a more general solution. It is anticipated that this general methodology may also find use for other lantibiotics, and potentially other classes of ribosomally synthesized and posttranslationally modified natural products.

Scheme 4.

Scheme 4

(A) Copper catalyzed azide-alkyne cycloaddition reaction between LctA(leader) and LctA(core) followed by enzymatic modification by LctM and photolysis to afford lacticin 481. (B) MALDI-TOF MS of the peptide before (blue) and after (red) the LctM assay. For core and leader sequences, see Scheme S1, ESI. TBTA = tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine.

Supplementary Material

suuplementary information

Acknowledgments

This work was supported by the National Institutes of Health (GM58822 to WAV).

Footnotes

This article is part of the `Enzymes and Proteins' web-theme issue for ChemComm.

Electronic supplementary information (ESI) available: General experimental procedures. Data and spectra for new compounds. See DOI: 10.1039/c0cc02945a

Notes and references

  • 1.Oman TJ, van der Donk WA. Nat. Chem. Biol. 2010;6:9. doi: 10.1038/nchembio.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.(a) Li YM, Milne JC, Madison LL, Kolter R, Walsh CT. Science. 1996;274:1152. doi: 10.1126/science.274.5290.1188. [DOI] [PubMed] [Google Scholar]; (b) Xie L, van der Donk WA. Curr. Opin. Chem. Biol. 2004;8:498. doi: 10.1016/j.cbpa.2004.08.005. [DOI] [PubMed] [Google Scholar]; (c) Clarke DJ, Campopiano DJ. Org. Biomol. Chem. 2007;5:2564. doi: 10.1039/b708478a. [DOI] [PubMed] [Google Scholar]; (d) Duquesne S, Destoumieux-Garzon D, Zirah S, Goulard C, Peduzzi J, Rebuffat S. Chem. Biol. 2007;14:793. doi: 10.1016/j.chembiol.2007.06.004. [DOI] [PubMed] [Google Scholar]; (e) Philmus B, Christiansen G, Yoshida WY, Hemscheidt TK. ChemBioChem. 2008;9:3066. doi: 10.1002/cbic.200800560. [DOI] [PubMed] [Google Scholar]; (f) Lee SW, Mitchell DA, Markley AL, Hensler ME, Gonzalez D, Wohlrab A, Dorrestein PC, Nizet V, Dixon JE. Proc. Natl. Acad. Sci. U. S. A. 2008;105:5879. doi: 10.1073/pnas.0801338105. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) Mitchell DA, Lee SW, Pence MA, Markley AL, Limm JD, Nizet V, Dixon JE. J. Biol. Chem. 2009;284:13004. doi: 10.1074/jbc.M900802200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.(a) Levengood MR, Kerwood CC, Chatterjee C, van der Donk WA. ChemBioChem. 2009;10:911. doi: 10.1002/cbic.200800752. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Levengood MR, Knerr PJ, Oman TJ, van der Donk WA. J. Am. Chem. Soc. 2009;131:12024. doi: 10.1021/ja903239s. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Levengood MR, van der Donk WA. Bioorg. Med. Chem. Lett. 2008;18:3025. doi: 10.1016/j.bmcl.2008.01.062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Håvarstein LS, Diep DB, Nes IF. Mol. Microbiol. 1995;16:229. doi: 10.1111/j.1365-2958.1995.tb02295.x. [DOI] [PubMed] [Google Scholar]
  • 5.(a) England PM, Lester HA, Davidson N, Dougherty DA. Proc. Natl. Acad. Sci. U. S. A. 1997;94:11025. doi: 10.1073/pnas.94.20.11025. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Peters FB, Brock A, Wang J, Schultz PG. Chem. Biol. 2009;16:148. doi: 10.1016/j.chembiol.2009.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Ramos R, Manning B, Aviñó A, Gargallo R, Eritja R. Helv. Chim. Acta. 2009;92:613. [Google Scholar]
  • 6.Lee HM, Priestman MA, Lawrence DS. J. Am. Chem. Soc. 2010;132:1446. doi: 10.1021/ja907427p. and references therein. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chan TR, Hilgraf R, Sharpless KB, Fokin VV. Org. Lett. 2004;6:2853. doi: 10.1021/ol0493094. [DOI] [PubMed] [Google Scholar]
  • 8.Maurel D, Banala S, Laroche T, Johnsson K. ACS Chem. Biol. 2010;5:507. doi: 10.1021/cb1000229. [DOI] [PubMed] [Google Scholar]
  • 9.(a) Marinzi C, Offer J, Longhi R, Dawson PE. Bioorg. Med. Chem. 2004;12:2749. doi: 10.1016/j.bmc.2004.02.039. [DOI] [PubMed] [Google Scholar]; (b) Olejnik J, Sonar S, Krzymanska-Olejnik E, Rothschild KJ. Proc. Natl. Acad. Sci. U. S. A. 1995;92:7590. doi: 10.1073/pnas.92.16.7590. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Walker JW, Reid GP, McCray JA, Trentham DR. J. Am. Chem. Soc. 1988;110:7170. [Google Scholar]
  • 10.Xie L, Miller LM, Chatterjee C, Averin O, Kelleher NL, van der Donk WA. Science. 2004;303:679. doi: 10.1126/science.1092600. [DOI] [PubMed] [Google Scholar]
  • 11.Furgerson Ihnken LA, Chatterjee C, van der Donk WA. Biochemistry. 2008;47:7352. doi: 10.1021/bi800278n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.(a) Paul M, Patton GC, van der Donk WA. Biochemistry. 2007;46:6268. doi: 10.1021/bi7000104. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Chatterjee C, Patton GC, Cooper L, Paul M, van der Donk WA. Chem. Biol. 2006;13:1109. doi: 10.1016/j.chembiol.2006.08.015. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

suuplementary information

RESOURCES